Method AI

Method AI is a private medical technology company developing an AI-backed, image-guided surgical navigation platform for robotic-assisted oncology procedures. The company combines continuous 3D ultrasound imaging, deep-tissue visualization, and machine learning to generate real-time surgical plans intended to help physicians identify subsurface anatomy and improve tumor resection accuracy. Method AI emerged from Cleveland Clinic in 2021 to address visualization challenges encountered in complex minimally invasive and robotic cancer surgeries. Its core offering appears to be a platform rather than a traditional drug pipeline, with early focus on surgical oncology applications and physician decision support during procedures. The company is based in the Boston/Cleveland ecosystem and has raised Series A financing to advance development of its novel ultrasound-enabled navigation system.